BAC
Bank of America Corporation
BAC has the edge over MFIN overall, supported by stronger modeled upside and stronger valuation.
MFIN
Medallion Financial Corp.
MFIN trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
MFIN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
MFIN's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like MFIN.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over MFIN in the historical PE scenario, which offers more potential upside but is not a forecast.
MFIN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 3.5x | $3.91 | -58% |
| Fair | 4.7x | $5.18 | -45% |
| Expensive | 6.7x | $7.41 | -21% |
| Current | 8.4x | $9.34 | — |
| Forward | 9.6x | $9.34 | — |
Historical ranges are pointers, not guarantees.
MFIN's PE is in its expensive range at 8.4x. Analysts expect earnings to fall, which would put today's price at 9.6x next year's earnings.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over MFIN on the outlook, with more favorable valuation and earnings expectations.
MFIN Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Strong decline | |
| Growth | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect MFIN's revenue to grow, but its earnings and profitability to decline. However, they disagree widely on these estimates.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over MFIN on earnings, with more consistent year-over-year improvement.
MFIN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.97 | -12% |
| Q3 2026 | $1.11 | -35% |
| Q2 2026 | $1.33 | -24% |
| Q1 2026 | $1.48 | -7.5% |
| Q4 2025 | $1.78 | +17% |
| Q3 2025 | $1.71 | +1.2% |
| Q2 2025 | $1.76 | -2.2% |
| Q1 2025 | $1.60 | -25% |
| Q4 2024 | $1.52 | -36% |
MFIN's earnings per share have fallen from their peak: $1.11 over the past year, against $2.37 in late 2023.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over MFIN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over MFIN on profitability, with a higher operating margin.
MFIN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $61.8M | +5.2% |
| Q2 2026 | $61.7M | -1.4% |
| Q1 2026 | $56.5M | -10% |
| Q4 2025 | $70.6M | +25% |
| Q3 2025 | $58.7M | +10% |
| Q2 2025 | $62.6M | +23% |
| Q1 2025 | $63M | +18% |
| Q4 2024 | $56.3M | +8.2% |
MFIN's revenue is growing: $62M last quarter, up 5.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | -22 points |
| Q2 2026 | 23% | -7.6 points |
| Q1 2026 | 21% | -12 points |
| Q4 2025 | 29% | -3.5 points |
| Q3 2025 | 33% | +6.6 points |
| Q2 2025 | 31% | +6.8 points |
| Q1 2025 | 32% | -1.4 points |
| Q4 2024 | 33% | -9.8 points |
MFIN's operating margin was 11% last quarter, down 22 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
MFIN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $44.6M | -33% |
| Q2 2026 | $17.5M | +$28.2M |
| Q1 2026 | $41.3M | +14% |
| Q4 2025 | $33.8M | +19% |
| Q3 2025 | $67M | +146% |
| Q2 2025 | -$10.7M | -139% |
| Q1 2025 | $36.3M | +12% |
| Q4 2024 | $28.4M | +45% |
MFIN has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over MFIN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
MFIN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -366K shares |
| 1 year | -3.2% | -790K shares |
| 3 years | +1.1% | +254K shares |
| 5 years | -5.4% | -1.3M shares |
| Available history | -2.9% | -696K shares |
MFIN has 24M diluted shares, down 3.2% from a year ago, with $13M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5.6M |
| Q2 2026 | $7.7M |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $455,000 |
| Q1 2025 | $531,000 |
| Q4 2024 | — |
MFIN spent $13M buying back its own shares over the past year, more than ten times what it spent the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
MFIN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.6x | Elevated |
| Q2 2026 | 2.4x | Moderate |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.1x | Moderate |
| Q3 2025 | 2.7x | Moderate |
| Q2 2025 | 2.3x | Moderate |
| Q1 2025 | 2.6x | Moderate |
| Q4 2024 | 2.8x | Moderate |
MFIN has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
MFIN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.5 | Neutral |
| Stochastic | 12.1 | Oversold |
MFIN's weekly RSI is 36 (neutral) and its Stochastic is 12 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
MFIN PE vs Financial Services Sector
| Metric | MFIN | Sector median | Relative |
|---|---|---|---|
| PE | 8.4x | 13x | 35% below |
| PE % | 85 | 63 | 22 pts above |
MFIN has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
MFIN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.0 | 15% below |
| 20 week MA | $11.0 | 15% below |
| 50 week MA | $10.2 | 8.8% below |
| 100 week MA | $9.84 | 5.1% below |
| 200 week MA | $9.02 | 3.5% above |
MFIN has fallen below most of its moving averages, though it's still 3.5% above its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over MFIN on returns for 2026, with the stronger performance.
MFIN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.15 | $5.20 | -27% |
| 2021 | $5.20 | $8.45 | +62% |
| 2022 | $8.45 | $6.91 | -18% |
| 2023 | $6.91 | $9.85 | +43% |
| 2024 | $9.85 | $9.37 | -4.9% |
| 2025 | $9.37 | $10.6 | +13% |
| 2026 YTD | $10.6 | $9.34 | -12% |
MFIN has finished lower in three of the last six years. It's down 12% so far in 2026.